Leadless Pacemaker Implantation Positions and Its Relationship with Procedure Efficacy and Complication
1 other identifier
interventional
196
1 country
1
Brief Summary
Leadless pacemakers (LP) are safe and effective alternatives to transvenous pacemakers in select patients. Advances in battery and electronics technology allow for the entire pacemaker system to be implanted into the right ventricle, bypassing many of the weaknesses of transvenous pacemakers. Traditionally leadless pacemakers have been implanted in the right ventricular (RV) septum to prevent cardiac perforation, and much emphasis is placed during implantation to ensure a septal implant. However, in Asians with smaller heart sizes, septal implantation may be unfeasible. Cases of RV free wall implant have been achieved without any complications. This study aims to examine patients previously implanted with LP and determine their final attachment location. If a substantial portion of complication-free patients had RV free wall implants, then it can be argued the additional effort to ensure a septal implant is unnecessary. Additionally, intraoperative data, such as the intracardiac electrogram, may contain parameters correlated with implant position. This study also aims to study this correlation to guide future implant procedures. This is a prospective-retrospective cohort study. Patients who will implant leadless pacemakers or already implanted leadless pacemakers since 1 Jan 2015 will be recruited. After the implantation, patients will be invited back for a noncontrast ECG-gated CT heart. It will be timed at the end diastole and a 3D reconstruction will be performed. The attachment of the leadless pacemaker to the RV will be adjudicated from the CT. The patients' pre-operative laboratory tests, baseline demographics, medical history, LP electrical data and pre- and post-operative medication regiment will be collected retrospectively from their medical records in the Hospital Authority's Clinical Management System (CMS) and Clinical Data Analysis and Reporting System (CDARS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2024
CompletedFirst Submitted
Initial submission to the registry
September 26, 2024
CompletedFirst Posted
Study publicly available on registry
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedNovember 18, 2024
September 1, 2024
1.2 years
September 26, 2024
November 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Location of leadless pacemaker implantation
Determine the exact location of leadless pacemaker implantation
From date of enrollment to date of CT or echocardiogram, up to 1 year
Secondary Outcomes (1)
Implant location prediction with electrical parameters
From date of enrollment to date of CT or echocardiogram, up to 1 year
Study Arms (1)
CT
OTHERAll patients will have a non-contrast, ECG-gated CT heart to adjudicate implant position of leadless pacemaker.
Interventions
Patients who will implant leadless pacemakers or already implanted leadless pacemakers since 1 Jan 2015 will be recruited. After the implantation, patients will be invited back for a noncontrast, ECG-gated CT heart. It will be timed at the end diastole and a 3D reconstruction will be performed.
Eligibility Criteria
You may qualify if:
- Patients who will implant leadless pacemaker or already implanted leadless pacemaker since 1 Jan 2015
- Patients with ability to provide informed consent
You may not qualify if:
- Patients who cannot provide informed consent
- Patient \< 18 years old
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 26, 2024
First Posted
November 18, 2024
Study Start
August 5, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
November 18, 2024
Record last verified: 2024-09